| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/30/2009 | US20090191256 High water content ophthalmic devices |
| 07/30/2009 | US20090191234 Vaccine |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | CA2712791A1 Fused pyridines active as inhibitors of c-met |
| 07/30/2009 | CA2712741A1 Hydrazines in glaucoma therapy |
| 07/29/2009 | CN101495185A Monoamine oxidase inhibitors useful for treating disorders of the outer retina |
| 07/29/2009 | CN101491520A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 07/29/2009 | CN100519539C N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100518735C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566720 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic |
| 07/28/2009 | US7566446 Wound healing and treatment of fibrosis |
| 07/28/2009 | CA2462453C Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 07/23/2009 | WO2009091894A1 Ophthalmic preparations |
| 07/23/2009 | WO2009091810A1 Methods for inhibiting angiogenesis using egfl8 antagonists |
| 07/23/2009 | WO2009091765A1 Therapeutic compounds |
| 07/23/2009 | WO2009091764A2 Beta-lactams for the treatment of glaucoma, ocular hypertension, baldness and hair loss |
| 07/23/2009 | WO2009090976A1 Transmucosal therapeutic preparation for nasal obstruction |
| 07/23/2009 | WO2009090239A1 Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 07/23/2009 | WO2009090085A1 Abnormal intraocular pressure treatment |
| 07/23/2009 | WO2009090081A1 Tetrahydropyridoethers for treatment of amd |
| 07/23/2009 | WO2009089680A1 Method of modulating membrane potential of a cell |
| 07/23/2009 | WO2009061431A3 Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor |
| 07/23/2009 | WO2009027803A3 Polymorphs of (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)- phenoxy)-acetic acid, free acid |
| 07/23/2009 | WO2009020848A8 RNAI-RELATED INHIBITION OF TNFα SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 07/23/2009 | WO2009020847A3 Rnai-related inhibition of tnfa signaling pathway for treatment of ocular angiogenesis |
| 07/23/2009 | WO2007126364A8 Use of antisecretory factors for treating intraocular hypertension |
| 07/23/2009 | US20090186917 6-And 7-amino isoquinoline compounds and methods for making and using the same |
| 07/23/2009 | US20090186908 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/23/2009 | US20090186885 Therapeutic compounds |
| 07/23/2009 | US20090186884 such as N-(3-amino-2-hydroxypropyl)-3-(1-(2-(2-ethylphenoxy)phenyl)-1-hydroxy-5-;methoxypentyl)piperidine-1-carboxamide, used for the treatment of cardiovascular disorders |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090186846 Methods to reprogram splice site selection in pre-messenger RNAs |
| 07/23/2009 | CA2749754A1 Tetrahydropyridoethers for treatment of amd |
| 07/23/2009 | CA2712264A1 Therapeutic beta-lactams |
| 07/23/2009 | CA2712192A1 Therapeutic compounds |
| 07/23/2009 | CA2711964A1 Abnormal intraocular pressure treatment |
| 07/23/2009 | CA2711708A1 Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 07/23/2009 | CA2710619A1 Inhibiting angiogenesis using egfl8 antagonists |
| 07/22/2009 | EP2080771A2 New interferon beta-like molecules |
| 07/22/2009 | EP2080520A1 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 07/22/2009 | EP2080513A1 Tetrahydropyridoethers for treatment of AMD |
| 07/22/2009 | EP2079749A2 Improved process for the preparation of (r)-(+)-4-(ethyiamino)-3,4-dihydro-2-(3- methoxypropyl)-2h-thieno[3,2-e]-l,2-thiazine-6-sulfonamide-l,l-dioxide |
| 07/22/2009 | EP2079465A2 Methods for treatment of cochlear and vestibular disorders |
| 07/22/2009 | EP1729753B1 Use of an nmda receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity |
| 07/22/2009 | EP1594498B1 Use of etazolate for the treatment of degenerative ocular pathologies |
| 07/22/2009 | EP1492761B1 Amino acids with affinity for the alpha-2-delta-protein |
| 07/22/2009 | EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 07/22/2009 | EP1392241B1 System for osmotic delivery of pharmaceutically active agents |
| 07/22/2009 | EP1115390B1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/22/2009 | CN101486682A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/22/2009 | CN100516200C Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof |
| 07/22/2009 | CN100516037C Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/21/2009 | US7563906 Indazole derivatives |
| 07/21/2009 | US7563824 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | US7563765 Histidine-rich glycoprotein |
| 07/21/2009 | CA2387486C Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/16/2009 | WO2009089399A2 Compositions comprising toll-like receptor or coreceptor antagonists and methods for ocular neuroprotection |
| 07/16/2009 | WO2009089284A2 Substituted 2-aminotetralin derivatives as selective alpha 2b agonist |
| 07/16/2009 | WO2009088997A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2009 | WO2009088939A2 Compositions and methods for treating neurodegenerative diseases |
| 07/16/2009 | WO2009088119A1 Composition for preventing or treating dry eye syndrome comprising poly-gamma-glutamic acid |
| 07/16/2009 | WO2009087900A1 Pharmaceutical agent for prevention or treatment of diseases accompanied by intraocular vascular hyperpermeability |
| 07/16/2009 | WO2009046198A3 Sustained delivery of compstatin analogs from gels |
| 07/16/2009 | US20090182057 Deuterated aminoglycidal compounds |
| 07/16/2009 | US20090182009 Compositions and methods of treating retinal disease |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181969 Hypotensive Lipid And Timolol Compositions And Methods Of Using Same |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181940 Imidazopyrazine Tyrosine Kinase Inhibitors |
| 07/16/2009 | US20090181918 Inhibition of pathological angiogenesis in vivo |
| 07/16/2009 | US20090181896 Use of Natriuretic Peptide Receptor Antagonists to Treat Ocular, Otic and Nasal Edemetous Conditions |
| 07/16/2009 | US20090181893 Use of agents that prevent generation of amyloid and amyloid-like lipoproteins, and/or use of agents that promote sequestration and/or degradation of, and/or prevent neurotoxicity of such proteins in the treatment of hearing loss and improving body balance |
| 07/16/2009 | US20090181032 facilitate drug delivery of other molecules; e.g. use intraocularly in eye surgery, glaucoma, retinopathy treatments |
| 07/16/2009 | US20090181017 Prevention and treatment of complement-associated eye conditions |
| 07/16/2009 | US20090181013 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/16/2009 | US20090180997 Mesenchymal Stem Cells And Uses Therefor |
| 07/16/2009 | US20090180986 Treating unwanted ocular conditions using an ascomycin macrolactam |
| 07/16/2009 | CA2711288A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/15/2009 | EP2078527A1 Aqueous liquid preparation comprising gatifloxacin |
| 07/15/2009 | EP2078526A1 Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 07/15/2009 | EP2078522A1 Composition for treating allergy |
| 07/15/2009 | EP2077840A1 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 07/15/2009 | EP1750664B1 Intravitreal implants in conjunction with photodynamic therapy to improve vision |
| 07/15/2009 | EP1519746B1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 07/15/2009 | EP1395278B1 Ocular tear growth factor-like protein |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100512809C Compounds and methods of treating transplant rejection |
| 07/14/2009 | US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy |
| 07/14/2009 | US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560471 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 07/14/2009 | US7560448 Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application |
| 07/14/2009 | US7560106 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 07/14/2009 | CA2521133C Use of dl-(+/-)-.alpha.-lipoic acid, d-(+)-.alpha.-lipoic acid, .alpha.-lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |